As a precursor to the Biotechnology Policy, the Government on Thursday announced its intention to work closely with the private sector for stem cell research. It will fund private sector to scale-up development of stem cells to be used by medical colleges for therapeutic treatment. The immediate focus is on looking for treatment of stroke and myocardial infarction, affecting part of the heart muscle which suddenly loses its blood supply. Without prompt treatment the condition can lead to damage to the affected part of the heart. Scientist will work on bone marrow mononuclear stem cell and mesenchymal stem from human cells derived umbilical-cord blood.